ArticleCancers2025

Clinical Utility of the EpiSwitch CiRT Test to Guide Immunotherapy Across Solid Tumors: Interim Results from the PROWES Study.

Joe Abdo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.